Trends in tuberculosis clinicians’ adoption of short-course regimens for latent tuberculosis infection

Objective: Little is known about regimen choice for latent tuberculosis infection in the United States. Since 2011, the Centers for Disease Control and Prevention has recommended shorter regimens—12 weeks of isoniazid and rifapentine or 4 months of rifampin—because they have similar efficacy, better...

Full description

Bibliographic Details

Published in:	Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Main Authors:	Pei-Jean I. Feng, David J. Horne, Jonathan M. Wortham, Dolly J. Katz
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Subjects:	Latent tuberculosis infection Short-course regimens
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405579423000384